Previous Article | Next Article 
Applied and Environmental Microbiology, June 2002, p. 3133-3137, Vol. 68, No. 6
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.6.3133-3137.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Vancomycin-Resistant Enterococcus faecium (VREF) from Norwegian Poultry Cluster with VREF from Poultry from the United Kingdom and The Netherlands in an Amplified Fragment Length Polymorphism Genogroup
Katrine Borgen,1,2* Yngvild Wasteson,1 Hilde Kruse,2 and Rob J. L. Willems3
Department of Pharmacology, Microbiology and Food Hygiene, The Norwegian School of Veterinary Science,1
National Veterinary Institute, N-0033 Oslo, Norway,2
Research Laboratory for Infectious Diseases, National Institute of Public Health and the Environment, 3720 BA Bilthoven, The Netherlands3
Received 2 August 2001/
Accepted 19 March 2002

ABSTRACT
The genetic relationship between 197 vancomycin-resistant
Enterococcus faecium (VREF) isolates and 21 vancomycin-susceptible
E. faecium isolates from Norwegian poultry was analyzed by amplified fragment
length polymorphism (AFLP). The isolates were compared to 255
VREF isolates from various sources and countries. The Norwegian
isolates constituted a relatively homogeneous population of
E. faecium and clustered in a previously defined poultry AFLP
genogroup.

INTRODUCTION
Vancomycin-resistant enterococci (VRE) have been of increasing
concern during the last 15 years as a cause of nosocomial infections,
particularly in the United States (
16). In the middle of the
1990s, an agricultural reservoir of the VanA type of VRE associated
with the use of avoparcin as a feed additive in livestock and
poultry was documented in Europe (
1,
3,
13,
14). To understand
the epidemiology of VRE, the genetic relationship between isolates
derived from human sources and isolates derived from animal
sources has been investigated in several studies. Fingerprinting
analyses have generally shown that the population of VRE outside
hospitals is heterogeneous, although indistinguishable or closely
related isolates from humans and animals have been described
(
9,
17,
18,
19). VRE isolated during hospital outbreaks and
from clinical specimens have revealed a more homogeneous population,
and both interhospital clonal dissemination of VRE and intrahospital
clonal dissemination of VRE have been reported (
7,
10). Pulse-field
gel electrophoresis (PFGE) has been regarded as the "gold standard"
for VRE typing in hospital epidemics (
15), but this typing method
may be too discriminatory to describe the genetic relatedness
of epidemiologically unrelated VRE (
21). A novel fingerprinting
method, amplified fragment length polymorphism (AFLP) analysis,
has recently been applied to enterococci and has been suggested
as a new gold standard for fingerprinting enterococci from nosocomial
outbreaks and in epidemiological studies (
2,
21).
In Norway, VanA-type VRE have been shown to persist in poultry production and to be present on broiler farms 4 years after avoparcin was banned (4, 5, 6). The aim of the present work was to study the genetic relationship between vancomycin-resistant Enterococcus faecium (VREF) and vancomycin-susceptible E. faecium (VSEF) isolates recovered from Norwegian poultry production between 1995 and 1999 by using AFLP and to compare these isolates with VREF isolates from both animal and human sources from other countries.
A selection of 197 VREF isolates (MICs of vancomycin,
256 µg/ml; vanA gene present) recovered from various poultry sources (4, 5, 6, 14) from 1995 to 1999, as well as 21 VSEF isolates (MICs of vancomycin, 0.38 to 1.0 µg/ml) recovered from poultry carcasses in 1998 (unpublished data), were studied (Table 1). Most isolates originated from different poultry flocks; the exceptions were nine carcass samples which each gave rise to one VREF isolate and one VSEF isolate. The VREF and VSEF isolates were in general susceptible to other antimicrobial agents, although some showed reduced susceptibility to tetracycline and/or erythromycin (4, 5, 6; unpublished data).
View this table:
[in this window]
[in a new window]
|
TABLE 1. Numbers of VREF and VSEF isolates recovered from various poultry sources in Norway at different times and analyzed by the AFLP method
|
AFLP analysis was performed as described by Willems et al. (
21).
GeneScan software (Applied Biosystems) was used for collection
of the data, which subsequently were exported into BioNumerics
(version 1.5; Applied Maths, St. Martens-Latem, Belgium) for
further analysis. The AFLP profiles of the 218 Norwegian isolates
were compared to each other, as well as to the AFLP profiles
of 255 VREF isolates from poultry, pigs, veal calves, dogs,
cats, hospitalized patients, and nonhospitalized persons from
other countries (
21). The effects of time period, source, and
vancomycin susceptibility on clustering of AFLP patterns in
the dendrogram were determined by using group statistics (K-means
partitioning) and the Jack-knife method (available in the BioNumerics
software) based upon maximal similarities between the isolates
(
BioNumerics Manual, version 1.5; Applied Maths). This method
determined the internal stability of the following predefined
groups: time period (1995, 1998, and 1999), source (feces, carcasses,
and environment), vancomycin susceptibility (resistant and susceptible),
and farm (farms 1 to 3 and 5).
AFLP typing of the 218 Norwegian E. faecium isolates revealed a homogeneous population that shared at least 75% of the restriction fragments. However, all but three isolates originated from a restricted area, the southeastern part of Norway, and the majority originated from only five broiler farms, which may have contributed to the genetic homogeneity observed. Grouping of isolates that shared
80% of the restriction fragments revealed seven AFLP groups (groups I to VII) (Fig. 1). The results of the grouping analysis suggested that clustering according to time of isolation occurred. Group separation statistics confirmed that specific clustering of isolates in time also occurred when the sources of isolation during the different time periods were taken into account (Table 2).
View this table:
[in this window]
[in a new window]
|
TABLE 2. Group separation statistics for distribution based on time period-, source-, vancomycin susceptibility-, and farm-specific isolates among the AFLP clusters in Fig. 1a
|
The majority of carcass and fecal isolates clustered in a restricted
number of AFLP groups (Fig.
1). Group separation statistics
showed a weak association between AFLP patterns and isolates
of carcass or fecal origin for 1998, while for 1995 no separation
between the carcass and feces groups was found. This supports
the assumption that poultry carcass isolates often are of fecal
origin. Of the 21 VSEF isolates from poultry carcasses, 62%
clustered in AFLP group V, while only two (10%) of the VREF
isolates recovered from poultry carcasses in the same period
of time (1998) clustered in this genogroup (Fig.
1). Group separation
statistics confirmed this genotypic difference between the VREF
and VSEF isolates included in the analysis (Table
2).
For farms 1, 2, and 3, AFLP typing revealed an association between genotype and farm of origin (Table 2), which suggests the presence of a farm-adapted E. faecium population. This is in concordance with results from Italy and Denmark showing clonal spread of VRE within a poultry flock or a pig herd at the same farm obtained by the use of PFGE (11, 12). The absence of an association between AFLP profiles and farm of origin for farms 4 and 5 is most probably due to the low number of isolates included. The homogeneity of the Norwegian AFLP profiles indicates that the VREF isolates recovered from farms in the absence of poultry are genetically related to VREF isolates recovered from poultry feces and carcasses. Consequently, these results support the hypothesis that recycling of VRE in the broiler farm environment is the most likely explanation for the continuing high prevalence of VRE seen in Norwegian poultry production (5).
When the AFLP profiles of the Norwegian isolates were compared to the AFLP profiles of 255 VREF isolates from other sources and countries (21), all the Norwegian isolates clustered in the previously defined poultry genogroup, genogroup B (Fig. 2). The finding that the Norwegian isolates clustered with poultry-associated isolates from The Netherlands and not with porcine or veal calf-associated isolates from The Netherlands strengthens the suggestion that clustering of poultry isolates is not a result of geographical isolation but is a result of adaptation of VREF to specific hosts (21). Most of the isolates of human origin in poultry genogroup B originated from humans with a history of poultry exposure. Carriage of VRE in healthy poultry slaughterers and farmers has previously been described (4, 14, 19), and transmission of VREF is likely to occur between poultry and humans in these settings. In contrast, infections with animal-derived VRE have rarely been reported (8), and it has been hypothesized that E. faecium strains causing infections or hospital epidemics are genetically distinct from animal-derived strains (20, 21). Further studies are needed to elucidate the differences and communication between various VRE populations.

ACKNOWLEDGMENTS
We thank Marga van Santen-Verheuvel and Marit Sørum for
excellent laboratory assistance.
The majority of this work was performed at the Research Laboratory for Infectious Diseases, National Institute of Public Health and the Environment, Bilthoven, The Netherlands, and was financially supported by FEMS fellowship 2000-2, as well as by grant 117130/112 from the Research Council of Norway.

FOOTNOTES
* Corresponding author. Present address: Research Laboratory for Infectious Diseases, National Institute of Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands. Phone: 31.30.2744073. Fax: 31.30.2744449. E-mail:
katrine.borgen{at}rivm.nl.


REFERENCES
1 - Aarestrup, F. M. 1995. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb. Drug Resist. 1:255-257.[Medline]
2 - Antonishyn, N. A., R. R. McDonald, E. L. Chan, G. Horsman, C. E. Woodmansee, P. S. Falk, and C. G. Mayhall. 2000. Evaluation of fluorescence-based amplified fragment length polymorphism analysis for molecular typing in hospital epidemiology: comparison with pulsed-field gel electrophoresis for typing strains of vancomycin-resistant Enterococcus faecium. J. Clin. Microbiol. 38:4058-4065.[Abstract/Free Full Text]
3 - Bager, F., M. Madsen, J. Christensen, and F. M. Aarestrup. 1997. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med. 31:95-112.[CrossRef][Medline]
4 - Borgen, K., G. S. Simonsen, A. Sundsfjord, Y. Wasteson, O. Olsvik, and H. Kruse. 2000. Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned. J. Appl. Microbiol. 89:478-485.[CrossRef][Medline]
5 - Borgen, K., M. Sorum, H. Kruse, and Y. Wasteson. 2000. Persistence of vancomycin-resistant enterococci (VRE) on Norwegian broiler farms. FEMS Microbiol. Lett. 191:255-258.[CrossRef][Medline]
6 - Borgen, K., M. Sorum, Y. Wasteson, and H. Kruse. 2001. VanA-type vancomycin-resistant enterococci (VRE) remain prevalent in poultry carcasses 3 years after avoparcin was banned. Int. J. Food Microbiol. 64:89-94.[CrossRef][Medline]
7 - Chow, J. W., A. Kuritza, D. M. Shlaes, M. Green, D. F. Sahm, and M. J. Zervos. 1993. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J. Clin. Microbiol. 31:1609-1611.[Abstract/Free Full Text]
8 - Das, I., A. Fraise, and R. Wise. 1997. Are glycopeptide-resistant enterococci in animals a threat to human beings? Lancet 349:997-998.[CrossRef][Medline]
9 - Descheemaeker, P. R., S. Chapelle, L. A. Devriese, P. Butaye, P. Vandamme, and H. Goossens. 1999. Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins. Antimicrob. Agents Chemother. 43:2032-2037.[Abstract/Free Full Text]
10 - Dunne, W. M., Jr., and W. Wang. 1997. Clonal dissemination and colony morphotype variation of vancomycin-resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan. J. Clin. Microbiol. 35:388-392.[Abstract]
11 - Grosso, M. D., A. Caprioli, P. Chinzari, M. C. Fontana, G. Pezzotti, A. Manfrin, E. D. Giannatale, E. Goffredo, and A. Pantosti. 2000. Detection and characterization of vancomycin-resistant enterococci in farm animals and raw meat products in Italy. Microb. Drug Resist. 6:313-318.[Medline]
12 - Hammerum, A. M., V. Fussing, F. M. Aarestrup, and H. C. Wegener. 2000. Characterization of vancomycin-resistant and vancomycin-susceptible Enterococcus faecium isolates from humans, chickens and pigs by RiboPrinting and pulsed-field gel electrophoresis. J. Antimicrob. Chemother. 45:677-680.[Abstract/Free Full Text]
13 - Klare, I., H. Heier, H. Claus, R. Reissbrodt, and W. Witte. 1995. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol. Lett. 125:165-171.[CrossRef][Medline]
14 - Kruse, H., B. K. Johansen, L. M. Rorvik, and G. Schaller. 1999. The use of avoparcin as a growth promoter and the occurrence of vancomycin-resistant Enterococcus species in Norwegian poultry and swine production. Microb. Drug Resist. 5:135-139.[Medline]
15 - Morrison, D., N. Woodford, S. P. Barrett, P. Sisson, and B. D. Cookson. 1999. DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J. Clin. Microbiol. 37:1084-1091.[Abstract/Free Full Text]
16 - Murray, B. E. 2000. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342:710-721.[Free Full Text]
17 - Robredo, B., K. V. Singh, C. Torres, and B. E. Murray. 2000. Streptogramin resistance and shared pulsed-field gel electrophoresis patterns in vanA-containing Enterococcus faecium and Enterococcus hirae isolated from humans and animals in Spain. Microb. Drug Resist. 6:305-311.[Medline]
18 - Simonsen, G. S., H. Haaheim, K. H. Dahl, H. Kruse, A. Lovseth, O. Olsvik, and A. Sundsfjord. 1998. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin- exposed farms. Microb. Drug Resist. 4:313-318.[Medline]
19 - Stobberingh, E., A. van den Bogaard, N. London, C. Driessen, J. Top, and R. Willems. 1999. Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob. Agents Chemother. 43:2215-2221.[Abstract/Free Full Text]
20 - Willems, R. J., W. Homan, J. Top, M. Santen-Verheuvel, D. Tribe, X. Manzioros, C. Gaillard, C. M. Vandenbroucke-Grauls, E. M. Mascini, E. van Kregten, J. D. van Embden, and M. J. Bonten. 2001. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357:853-855.[CrossRef][Medline]
21 - Willems, R. J., J. Top, B. N. van Den, A. Van Belkum, H. Endtz, D. Mevius, E. Stobberingh, B. A. van Den, and J. D. van Embden. 2000. Host specificity of vancomycin-resistant Enterococcus faecium. J. Infect. Dis. 182:816-823.[CrossRef][Medline]
Applied and Environmental Microbiology, June 2002, p. 3133-3137, Vol. 68, No. 6
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.6.3133-3137.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sorum, M., Johnsen, P. J., Aasnes, B., Rosvoll, T., Kruse, H., Sundsfjord, A., Simonsen, G. S.
(2006). Prevalence, Persistence, and Molecular Characterization of Glycopeptide-Resistant Enterococci in Norwegian Poultry and Poultry Farmers 3 to 8 Years after the Ban on Avoparcin. Appl. Environ. Microbiol.
72: 516-521
[Abstract]
[Full Text]
-
Kuhn, I., Iversen, A., Finn, M., Greko, C., Burman, L. G., Blanch, A. R., Vilanova, X., Manero, A., Taylor, H., Caplin, J., Dominguez, L., Herrero, I. A., Moreno, M. A., Mollby, R.
(2005). Occurrence and Relatedness of Vancomycin-Resistant Enterococci in Animals, Humans, and the Environment in Different European Regions. Appl. Environ. Microbiol.
71: 5383-5390
[Abstract]
[Full Text]
-
Garcia-Migura, L., Pleydell, E., Barnes, S., Davies, R. H., Liebana, E.
(2005). Characterization of Vancomycin-Resistant Enterococcus faecium Isolates from Broiler Poultry and Pig Farms in England and Wales. J. Clin. Microbiol.
43: 3283-3289
[Abstract]
[Full Text]
-
Johnsen, P. J., Osterhus, J. I., Sletvold, H., Sorum, M., Kruse, H., Nielsen, K., Simonsen, G. S., Sundsfjord, A.
(2005). Persistence of Animal and Human Glycopeptide-Resistant Enterococci on Two Norwegian Poultry Farms Formerly Exposed to Avoparcin Is Associated with a Widespread Plasmid-Mediated vanA Element within a Polyclonal Enterococcus faecium Population. Appl. Environ. Microbiol.
71: 159-168
[Abstract]
[Full Text]
-
Jureen, R., Top, J., Mohn, S. C., Harthug, S., Langeland, N., Willems, R. J. L.
(2003). Molecular Characterization of Ampicillin-Resistant Enterococcus faecium Isolates from Hospitalized Patients in Norway. J. Clin. Microbiol.
41: 2330-2336
[Abstract]
[Full Text]
-
Werner, G., Willems, R. J. L., Hildebrandt, B., Klare, I., Witte, W.
(2003). Influence of Transferable Genetic Determinants on the Outcome of Typing Methods Commonly Used for Enterococcus faecium. J. Clin. Microbiol.
41: 1499-1506
[Abstract]
[Full Text]